Cost-Effectiveness Analysis of Angiotensin Receptor Neprilysin Inhibitor Compared With Angiotensin-Converting Enzyme Inhibitor Among Patients With Heart Failure With Reduced Ejection Fraction in Malaysia
At the cost-effectiveness threshold of RM55 426 per QALY, ARNI is cost-effective compared with ACEI for the heart failure with reduced ejection fraction population. Expanding patient access to ARNI is likely to improve health outcomes cost-effectively.
Authors
- Julia Fox‐Rushby (ORCID: https://orcid.org/0000-0003-0748-0871)
- Sazzli Kasim (ORCID: https://orcid.org/0000-0003-4585-7713)
- Kok Han Chee (ORCID: https://orcid.org/0000-0002-4485-0504)
- Zanfina Ademi (ORCID: https://orcid.org/0000-0002-0625-3522)
- Juman Abdulelah Dujaili (ORCID: https://orcid.org/0000-0002-7515-5344)
- Kenneth Kwing-Chin Lee
- Raja Ezman Raja Shariff (ORCID: https://orcid.org/0000-0002-5167-5863)
- Siew Chin Ong (ORCID: https://orcid.org/0000-0002-9750-9588)
- Sit Wai Lee
- Wai-Chee Kuan (ORCID: https://orcid.org/0000-0002-6243-1194)
- Azmee Mohd Ghazi (ORCID: https://orcid.org/0000-0003-1623-404X)
- Siew Li Teoh (ORCID: https://orcid.org/0000-0003-4163-7895)
- Ka Keat Lim (ORCID: https://orcid.org/0000-0002-2340-4097)
- Siddesh Shetty (ORCID: https://orcid.org/0000-0003-0696-1622)
- M.A.S.K. Abdul Kader
Institutions
- Ministry of Health (MY)
- Monash University Malaysia (MY)
- University Malaya Medical Centre (MY)
- Universiti Sains Malaysia (MY)
- Serdang Hospital (MY)
- University of Malaya (MY)
- Swansea University (GB)
- National Heart Institute (MY)
- Hospital Sungai Buloh (MY)
- Monash University (AU)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1016/j.vhri.2025.101118
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00